RPTP Headlines | Raptor Pharmaceutical Corp. Stock - Yahoo! Finance

Thu, May 2, 2013, 6:18PM EDT - U.S. Markets closed

Dow

0.89% Nasdaq

1.26%

More On RPTP

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Raptor Pharmaceuticals Corp. (RPTP)

-NasdaqGM

6.17 0.51(7.63%) 4:00PM EDT|After Hours : 6.17 0.00 (0.02%) 4:45PM EDT

Add to Portfolio

Headlines

Get Headlines for:

Thursday, May 2, 2013

Two Different Outlooks for Two Tuesday Performersat Motley Fool (Thu 5:20PM EDT)
Raptor Pharmaceuticals downgraded to Neutral from Outperform at Wedbushtheflyonthewall.com (Thu 7:24AM EDT)

Wednesday, May 1, 2013

Multimedia Now Available: Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic CystinosisPR Newswire (Wed, May 1)
Wall Street Transcript Interview with Boris Peaker, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.: Finding Innovation in Biotechnology for Cell Therapy, Oncology and Orphan DrugsWall Street Transcript (Wed, May 1)
RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Wed, May 1)
3 Healthcare Stock Stories For Tuesday Portfolio Wellnessat Wall St. Cheat Sheet (Wed, May 1)
Raptor's FDA Approval Is New Test For Orphan Drug Pricingat TheStreet (Wed, May 1)

Tuesday, April 30, 2013

Why Raptor Pharmaceuticals Shares Spiked and Then Droppedat Motley Fool (Tue, Apr 30)
3 Pharmaceutical Companies Awaiting FDA Approval, Part IIat Seeking Alpha (Tue, Apr 30)
Raptor Drug Wins U.S. Approval to Treat Rare Diseaseat Bloomberg (Tue, Apr 30)
InPlay: Raptor Pharma confirms PROCYSBI receives FDA approval for the treatment of nephropathic cystinosisBriefing.com (Tue, Apr 30)
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic CystinosisPR Newswire (Tue, Apr 30)
UPDATE 1-U.S. FDA approves Raptor's drug for nephropathic cystinosisat Reuters (Tue, Apr 30)
Expert Analyst Ian Somaiya Discusses the Decline in European Drug Pricing with The Wall Street Transcript; Models a 1% to 2% Annual Decline in Price for Companies That Sell OverseasWall Street Transcript (Tue, Apr 30)

Sunday, April 28, 2013

2 FDA Decisions You Can't Afford to Miss This Weekat Motley Fool (Sun, Apr 28)

Friday, April 26, 2013

Analysts: Pfizer Shares Won’t Suffer From Negative Decision and 3 Other Research Notes To Readat Wall St. Cheat Sheet (Fri, Apr 26)

Thursday, April 25, 2013

Six breakout stocks to watchat MarketWatch (Thu, Apr 25)

Wednesday, April 24, 2013

2 Orphan Drugmakers With Upcoming Catalystsat Motley Fool (Wed, Apr 24)

Monday, April 22, 2013

Analysts: Apple’s Outlook Will Point Below Consensus and 3 Other Research Notes To Look Intoat Wall St. Cheat Sheet (Mon, Apr 22)

Tuesday, April 9, 2013

RAPTOR PHARMACEUTICAL CORP Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online (Tue, Apr 9)

Older Headlines

Add RPTP News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.